FDA Clarifies Distinction Between Device Remanufacturing and Servicing in Final Guidance

Start
While the US Food and Drug Administration’s recently issued Final Guidance on Remanufacturing of Medical Devices provides clarity and attempts to reign in certain activities, the agency continues to defer enforcement for servicing performed by independent third parties….
By: Morgan Lewis
Previous Story

Here We Go Again: Another Attempt at a Comprehensive Federal Data Privacy Law

Next Story

Talc Defendant’s Motion for Summary Judgment Based on Texas Law Granted on Appeal